Literature DB >> 26596921

Crohn's Disease of the Foregut.

Kurt G Davis1.   

Abstract

Crohn's disease of the foregut is more common than previously recognized, with up to 40% of patients with Crohn's disease in the distal intestine also having evidence of foregut disease. Esophageal disease is best managed medically with proton pump inhibition, steroids, thiopurines, methotrexate, and anti-tumor necrosis factor-α biologic medications. Esophageal strictures are dealt with using endoscopic dilation. Surgery is generally reserved of resistant strictures or esophageal fistulas. Patients with gastroduodenal disease more commonly come to surgery. The most commonly performed operations for gastroduodenal Crohn's disease are intestinal bypass or strictureplasty. The concomitant use of vagotomy remains controversial. Published by Elsevier Inc.

Entities:  

Keywords:  Crohn’s disease; Esophagus; Foregut; Gastric

Mesh:

Year:  2015        PMID: 26596921     DOI: 10.1016/j.suc.2015.07.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.

Authors:  Christina Ling; Michael Gavin; Joshua Hanson; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2018-07       Impact factor: 3.199

Review 2.  Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Authors:  Diana Muñoz-Mendoza; Adrián Chapa-Rodríguez; Sami L Bahna
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

Review 3.  Medical, Endoscopic and Surgical Management of Stricturing Crohn's Disease: Current Clinical Practice.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Kostas Tepelenis; George Pappas-Gogos; Konstantinos H Katsanos; Georgios D Lianos; Francesco Frattini; Konstantinos Vlachos; Dimitrios K Christodoulou
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

Review 4.  Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview.

Authors:  Vidal Delgado-Rizo; Marco A Martínez-Guzmán; Liliana Iñiguez-Gutierrez; Alejandra García-Orozco; Anabell Alvarado-Navarro; Mary Fafutis-Morris
Journal:  Front Immunol       Date:  2017-02-06       Impact factor: 7.561

5.  Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn's disease: a case report.

Authors:  Sunina Nathoo; William A Hood; Sara Keihanian; Amy L Collinsworth; Sarah C Glover
Journal:  J Med Case Rep       Date:  2016-09-23

6.  Ulcerous Esophagitis in a Young Immunocompetent Patient.

Authors:  Lídia Roque Ramos; Rita Barosa; Pedro C Figueiredo; Tânia Meira; Helder Oliveira; João Freitas
Journal:  GE Port J Gastroenterol       Date:  2016-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.